CHINESE MEDICINAL BIOTECHNOLOGY
Bimonthly
Established in December 2006
Responsible Institution
Ministry of Health of the People’s
Republic of China
Sponsor
China Medicinal Biotech Association
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Editing
Editorial
Board
of
Medicinal Biotechnology
Chinese
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmbj01@126.com
http://www.cmbp.net.cn
Editor-in-Chief
ZHAO Kai（赵铠）
Managing Director
YAN Ming（燕鸣）
Publishing
China Medicinal Biotech Association
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmba@cmba.org.cn
Printing
Beijing Zhongke Printing Limited
Company
Mail-Order
Editorial Department of Chinese
Medicinal Biotechnology
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmbj01@126.com
CSSN
ISSN 1673-713X
CN 11- 5512 / R
Copyright© 2007 by the China
Medicinal Biotech Association
Volume 2, Number 6
December 10, 2007
CONTENTS OF SELECTED ARTICLES
Editorial
Progress and prospect of human islet transplantation for
treatment of diabetes ………………………………………………………… 401
CAI Han-qing, LOU Jin-ning
Original Articles
Effect of phospholipase inhibitor okadaic acid on HBV
replication in HepG2.2.15 cells ……………………………………………… 405
PAN Xiao-ben, JI Ying, ZHU Ling, WANG Qian, GUAN Wen-li, HAN Jin-chao, WEI Lai
Differentiation of mouse bone marrow mesenchymal stem cells
induced by infarcted myocardium lysate in vitro ………………………… 411
ZHAO Jin-chao, GU Chun-hu, WANG Yun-ya, WEI Xu-feng ,
DONG Xiao-chao, LIU Jin-cheng, WANG Yun, YI Ding-hua
In vitro cytotoxic and in vivo targeting effects of TCRVβ7.1
gene-modified T cells on liver cancer cells ……………………………… 416
LÜ Li-shan, WANG Jin-quan, SHAO Hong-wei, HUANG Shu-lin
Rapid identification of mycobacterium by genes chips technique ……… 422
ZHAO Yuan, HU Zhong-yi, JING Feng-xiang, LIU Zhi-hui, WANG Jie,
ZHENG Rui-juan, LU Jun-mei, ZHAO Hui, YIN Jun
Interactions between sHLA-G1 and its receptors ILT2,
and KIR2DL4 on NK-92 cells ……………………………………………… 428
WEI Jiao, ZHANG Hai-quan, YU Yan-rong, Muti-Ur-Rehman Khan,
WANG Yun, DENG Li, FENG Mei-fu
125I
seeds implantation as brachytherapy in nude mice
bearing human breast cancer ………………………………………………… 435
CUI Xue-jun, LIU Zeng-li, ZHANG Zhi-yong, SHI Yi-zhen, TANG Jun, YANG Yi
Expression of ezrin protein in gastric cancer
and its clinical significance ………………………………………………… 441
LI Guo-fang, FENG Mao-hui, XIE Wei, GONG Ling-ling, CHENG Tian-tian
Reviews
Progress on Pin1-targeted antisense gene therapy for cancer …………… 445
SUN Huan-xing, SHAO Rong-guang
Advancement in the research of puma in apoptosis promotion …………… 449
LIU Yong-jun, QIAN Hai-li, LIN Chen
Progress on the function of IFN-λ family …………………………………… 452
LIU Xiao-jin, LI Ming-cai, SU Shao-bo
Progress on the role of Wnt/β-catenin pathway in tumor stem cells …… 455
WEN Ping, HU Wei-hua, DOU Jun
Progress on the application of thymidine kinase 1 to the diagnosis and
prognosis of breast cancer …………………………………………………… 458
SHEN Jin-gen, ZHENG Li, JING Ning, XIONG Xiao-yan
All articles published represent the
opinions of the authors, not reflecting
the official policy of the China
Medicinal Biotech Association or the
Editorial Board of Chinese Medicinal
Biotechnology, unless this is clearly
specified.
Technology and Methods
Application of immunoenzymatic technique to titration
test of modified vaccinia Ankara virus …………………………………… 461
CHEN Dan, YU Liang, ZHANG Yin-chuan, ZHOU Dong-xia, HUANG Xiao-qin, CHU Jia-you
Establishment and verification of neutralization method for
smallpox vaccine Tiantan strain …………………………………………… 464
DONG Xiao-man, CHEN Xiu-zhen, DONG Yi, LÜ Yang
Discussion and Contention
Establishment of a biosafety management system in
biosafety level 3 laboratories ………………………………………………… 467
LI Yong, LU Feng-min, ZHANG Feng-min, FU Jiang-nan, LAI Xiao-min,
FAN Wei-min, XING Wen-ge, WANG Jian-hua